← Leaderboards
Grazyna Adamus
Oregon Health And Science University
$4,345,889
Attributed
$4,345,889
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $938.4K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$4,345,889 · 6
By mechanism
R01$2,933,606 · 2
R42$757,363 · 1
P51$554,194 · 2
R41$100,726 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- James T Rosenbaum$22,148,617
- Justine R Smith$3,257,492
- Tammy M Martin$4,039,697
- William D Mathers$673,247
- Rae Nishi$10,112,269
Others in their field
Top investigators on “Pathologic Process”
- Paul S. Aisen · Cognition Therapeutics, Inc.$141,221,127
- Reisa A. Sperling · Banner Health$136,913,444
- Constance Ann Benson · University Of California, San Diego$114,806,215
- David A Bennett · Rush University Medical Center$85,949,086
- Stephen A Spector · University Of California, San Diego$77,513,450
- Randall J Bateman · Washington University$70,562,221
Research focus
Pathologic ProcessLaboratory RatApoptosisTissue /Cell CultureCytotoxicityElectroretinographyAutoantibodyDisease /Disorder ModelModel Design /DevelopmentBcl2 Gene /ProteinRetina DegenerationHuman SubjectAutoimmune DisorderCellular ImmunityClinical ResearchCytokineInflammationUveitisAutoantibodiesMedicalIn VivoAffectBlindnessBase
Grant awards (16)
Recombinant T Cell Receptor Ligands for Treatmentof Uveitis$375,338
R42 · FY2010 · EY · contact PI
Recombinant T Cell Receptor Ligands for Treatmentof Uveitis$382,025
R42 · FY2009 · EY · contact PI
Mechanism of Retinal Damage in Autoimmune Retinopathy$369,262
R01 · FY2008 · EY · contact PI
Mechanism of Retinal Damage in Autoimmune Retinopathy$376,711
R01 · FY2007 · EY · contact PI
Mechanism of Retinal Damage in Autoimmune Retinopathy$377,389
R01 · FY2006 · EY · contact PI
Recombinant T-cell Receptor Ligands for Treatment of Uveitis$100,726
R41 · FY2006 · EY · contact PI
ADVANCED IMAGING CENTER$474,194
P51 · FY2005 · RR
Mechanism of Retinal Damage in Autoimmune Retinopathy$384,170
R01 · FY2005 · EY
TRAINING OF INDIA OR CHINA PERSONNEL IN PRIMATOLOGY$80,000
P51 · FY2005 · RR
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY$101,653
R01 · FY2004 · EY
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY$203,050
R01 · FY2003 · EY
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY$203,050
R01 · FY2002 · EY
IMMUNOLOGICAL MECHANISM OF INFLAMMATION IN UVEITIS &EAE$259,895
R01 · FY2001 · EY
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY$203,050
R01 · FY2001 · EY
IMMUNOLOGICAL MECHANISM OF INFLAMMATION IN UVEITIS &EAE$252,326
R01 · FY2000 · EY
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY$203,050
R01 · FY2000 · EY